247 related articles for article (PubMed ID: 28733878)
1. Role of TGF-β in Self-Peptide Regulation of Autoimmunity.
Singh B; Krawetz MD; De Lima RM; Mukherjee R; Chaturvedi P; Lee-Chan E; Leiter EH; Summers KL
Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):11-19. PubMed ID: 28733878
[TBL] [Abstract][Full Text] [Related]
2. Regulation of type 1 diabetes by a self-MHC class II peptide: role of transforming growth factor beta (TGF-beta).
Mukherjee R; Chaturvedi P; Agrawal B; Singh B
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):159-69. PubMed ID: 12887099
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
4. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
[TBL] [Abstract][Full Text] [Related]
5. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
Tisch R; Wang B; Serreze DV
J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.
Prasad S; Kohm AP; McMahon JS; Luo X; Miller SD
J Autoimmun; 2012 Dec; 39(4):347-53. PubMed ID: 22647732
[TBL] [Abstract][Full Text] [Related]
7. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
[TBL] [Abstract][Full Text] [Related]
8. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin.
Zhang W; Jin H; Hu Y; Yu Y; Li X; Ding Z; Kang Y; Wang B
Hum Gene Ther; 2010 Feb; 21(2):171-8. PubMed ID: 19788384
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
Li L; Yi Z; Wang B; Tisch R
J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
[TBL] [Abstract][Full Text] [Related]
10. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
11. Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.
Chen W; Bergerot I; Elliott JF; Harrison LC; Abiru N; Eisenbarth GS; Delovitch TL
J Immunol; 2001 Nov; 167(9):4926-35. PubMed ID: 11673498
[TBL] [Abstract][Full Text] [Related]
12. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M
Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130
[TBL] [Abstract][Full Text] [Related]
13. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
14. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
[TBL] [Abstract][Full Text] [Related]
16. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
17. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.
Yi W; Seth NP; Martillotti T; Wucherpfennig KW; Sant'Angelo DB; Denzin LK
J Clin Invest; 2010 Apr; 120(4):1324-36. PubMed ID: 20200448
[TBL] [Abstract][Full Text] [Related]
18. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes.
Gregg RK; Jain R; Schoenleber SJ; Divekar R; Bell JJ; Lee HH; Yu P; Zaghouani H
J Immunol; 2004 Dec; 173(12):7308-16. PubMed ID: 15585854
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
[TBL] [Abstract][Full Text] [Related]
20. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
